Aphelion Managing Partner Ned Scheetz Discusses Medtech Investor’s Unique Approach, Unusual Name

Medtech Talk

English - July 30, 2018 04:00 - 32 minutes - 58.8 MB - ★★★★★ - 56 ratings
Investing Business Health & Fitness medtech medical device venture capital health care innovation cardiology start-ups orthopedics digital health fda Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Relievant CEO Kevin Hykes Shares the Advice that Led Him to Set a Successful Course as CEO

Next Episode: Medcrypt CEO Mike Kijewski Says Medtech Cybersecurity Is a Growing Concern for Hospitals, Patients

Medtech start-ups need more firms like Aphelion Capital, investors willing to wager as little as $200,000 to get a promising idea going. Managing Partner Ned Scheetz discusses the firm’s origins, name, and plans going forward. This is the first of a two-episode package highlighting a unique joint effort between Aphelion and other co-creators of Cardeation Capital.